歡迎光臨源葉生物,登錄 | 注冊 |
當(dāng)前位置: 首頁 > 小分子抑制劑 > JAK/STATsignaling > S3I-201

瀏覽歷史

S80750

S3I-201

源葉(MedMol) 98%
  • 英文名:
  • S3I-201
  • 別名:
  • 2-hydroxy-4-(2-(tosyloxy)acetamido)benzoic acid
  • CAS號:
  • 501919-59-1
  • 分子式:
  • C16H15NO7S
  • 分子量:
  • 365.36
  • MDL:
  • MFCD09907564
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S80750-5mg 98% ¥192.00元 4 - - - EA 加入購物車
源葉(MedMol) S80750-10mg 98% ¥352.00元 2 - - - EA 加入購物車
源葉(MedMol) S80750-25mg 98% ¥600.00元 3 - - - EA 加入購物車
源葉(MedMol) S80750-50mg 98% ¥880.00元 4 - - - EA 加入購物車
源葉(MedMol) S80750-100mg 98% ¥1440.00元 預(yù)計交期:2-3天 - - - EA 加入購物車
源葉(MedMol) S80750-200mg 98% ¥2720.00元 預(yù)計交期:2-3天 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: NSC 74859 (S3I-201) is a selective Stat3 inhibitor with an IC50 of 86 μM
  • 靶點(diǎn): STAT3:86 μM (IC50);STAT
  • 體內(nèi)研究:
    Human breast (MDA-MB-231) tumor-bearing mice are given an i.v. injection of NSC 74859 (S3I-201) or vehicle every 2 or every 3 days for 2 weeks, and tumor measurements are taken every 2-3 days. Compared with control (vehicle-treated) tumors, which continued to grow, human breast tumors in mice that received S3I-201 display strong growth inhibition. Continued evaluation of treated mice on termination of treatment shows no resumption of tumor growth, suggesting potentially a long-lasting effect of S3I-201 on tumor growth. Compared with vehicle-treated control tumors (n=15), which continued to grow, S3I-201 treatment of somatotroph tumor xenografts (n=15) significantly attenuated tumor growth for the duration of the experiment. Tumors derived from NSC 74859-treated rats are significantly smaller than those from the untreated group (220±16 mm3?vs. 287±16 mm3, P<0.01) as early as 5 days after NSC 74859 injection. Fifteen days after treatments, the average tumor volume of NSC 74859-treated rats is 64% of that of controls (449±40 mm3?vs. 708±83 mm3, P<0.01). Rats are sacrificed and tumors are harvested 15 days after treatment initiation. The average tumor weight of NSC 74859-treated rats is 78±8 mg, while tumors derived from control rats weighed 114±13 mg (32% reduction; P<0.05).
  • 參考文獻(xiàn):
    1. Siddiquee K, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci U S A. 2007 May 1;104(18):7391-6. 2. Lin L, et al. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling. Oncogene. 2009 Feb 19;28(7):961-72. 3. Zhou C, et al. STAT3 upregulation in pituitary somatotroph adenomas induces hypersecretion. J Clin Invest. 2015 Apr;125(4):1692-702
  • 溶解性: DMSO  :  100  mg/mL  (273.70  mM;  Need  ultrasonic)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.737 ml 13.685 ml 27.37 ml
    5 mM 0.547 ml 2.737 ml 5.474 ml
    10 mM 0.274 ml 1.369 ml 2.737 ml
    50 mM 0.055 ml 0.274 ml 0.547 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。